| pubmed-article:9257313 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9257313 | lifeskim:mentions | umls-concept:C0001483 | lld:lifeskim |
| pubmed-article:9257313 | lifeskim:mentions | umls-concept:C0019348 | lld:lifeskim |
| pubmed-article:9257313 | lifeskim:mentions | umls-concept:C0017296 | lld:lifeskim |
| pubmed-article:9257313 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:9257313 | lifeskim:mentions | umls-concept:C0927232 | lld:lifeskim |
| pubmed-article:9257313 | lifeskim:mentions | umls-concept:C0031727 | lld:lifeskim |
| pubmed-article:9257313 | lifeskim:mentions | umls-concept:C1514300 | lld:lifeskim |
| pubmed-article:9257313 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9257313 | pubmed:dateCreated | 1997-9-30 | lld:pubmed |
| pubmed-article:9257313 | pubmed:abstractText | Adenoviral gene transfer and killing efficiency using the thymidine kinase (TK)/ganciclovir (GCV) mechanism was evaluated in human cancer cells occurring as central nervous system tumors. The effectiveness of this approach was tested in vitro and in experimental models for brain tumor and leptomeningeal metastases in rats in vivo. Recombinant adenoviruses with different promoters were compared. | lld:pubmed |
| pubmed-article:9257313 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9257313 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9257313 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9257313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9257313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9257313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9257313 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9257313 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:9257313 | pubmed:issn | 0148-396X | lld:pubmed |
| pubmed-article:9257313 | pubmed:author | pubmed-author:van BekkumD... | lld:pubmed |
| pubmed-article:9257313 | pubmed:author | pubmed-author:ValerioDD | lld:pubmed |
| pubmed-article:9257313 | pubmed:author | pubmed-author:BousFF | lld:pubmed |
| pubmed-article:9257313 | pubmed:author | pubmed-author:AvezaatC JCJ | lld:pubmed |
| pubmed-article:9257313 | pubmed:author | pubmed-author:VechtC JCJ | lld:pubmed |
| pubmed-article:9257313 | pubmed:author | pubmed-author:HoogerbruggeP... | lld:pubmed |
| pubmed-article:9257313 | pubmed:author | pubmed-author:VincentA JAJ | lld:pubmed |
| pubmed-article:9257313 | pubmed:author | pubmed-author:EsandiM CMC | lld:pubmed |
| pubmed-article:9257313 | pubmed:author | pubmed-author:Sillevis... | lld:pubmed |
| pubmed-article:9257313 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9257313 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:9257313 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9257313 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9257313 | pubmed:pagination | 442-51; discussion 451-2 | lld:pubmed |
| pubmed-article:9257313 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:meshHeading | pubmed-meshheading:9257313-... | lld:pubmed |
| pubmed-article:9257313 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9257313 | pubmed:articleTitle | Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies. | lld:pubmed |
| pubmed-article:9257313 | pubmed:affiliation | Department of Neurosurgery, University Hospital Rotterdam, The Netherlands. | lld:pubmed |
| pubmed-article:9257313 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9257313 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
